Abstract
The AI-driven ‘endo-histo-omics’ approach integrates clinical, endoscopic, histological and molecular data to improve management of inflammatory bowel disease. This strategy enables precise patient stratification and outcome prediction, paving the way for advanced intestinal barrier assessment and restoration, thereby driving progress in personalized care.
| Original language | English |
|---|---|
| Article number | 1470 |
| Pages (from-to) | 362-363 |
| Number of pages | 2 |
| Journal | Nature Reviews Gastroenterology and Hepatology |
| Volume | 22 |
| Issue number | 6 |
| DOIs |
|
| Publication status | Published - Jun 2025 |
Fingerprint
Dive into the research topics of 'AI-enabled ‘endo-histo-omics’: breaking down intestinal barriers in IBD'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver